Course Experts: Hannah McDermott, PharmD

Course Description: This course prepares pharmacists to evaluate the safe and evidence-based use of herbal products and dietary supplements in oncology care for symptom management and supportive treatment. Participants will assess safety considerations, review the available clinical evidence, and develop patient-centered recommendations based on efficacy and toxicity data.

[DFCI_KEYWORDS] Chronic Lymphocytic Leukemia (CLL), Bruton’s Tyrosine Kinase (BTK) Inhibitors, Pathophysiology, Prognostic Markers, Genetic Markers, Cytogenetics, Ibrutinib, Acalabrutinib, Zanubrutinib, Pirtobrutinib, Lymphocytes, Lymphadenopathy, Venetoclax, Obinutuzumab, Rituximab, Fludarabine, Bendamustine, Antiplatelet, Anticoagulation, Leukocytosis